Intimation of Transcript of Q2 FY 26 for the Earnings Conference Call held on October 17, 2025.
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech has submitted the transcript of its Q2 FY26 earnings conference call, held on October 17, 2025, to the stock exchanges as a routine SEBI listing-regulation filing. The transcript documents management's commentary on quarterly results, business segments, and responses to analyst queries. Without access to the full transcript content in this filing, specific financial figures, guidance points, or strategic updates cannot be quoted here. Retail investors are encouraged to read the transcript on the company's website or BSE/NSE portal for complete management views. This intimation itself carries no new financial information beyond what was already shared during the live call.
No immediate price impact expected as this is a post-call procedural filing, though the transcript may serve as a useful reference for management's stated outlook on growth, margins, and strategy.